Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

SEATTLE — May 6, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re covering the annual meeting of the American Society of Gene ...

Yale researchers are providing new insights into how physical forces, such as cells being compressed in physically restrictive environments, play key roles in cancer progression. By analyzing liver ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple ...

New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...

For almost 60 years, scientists have tried to understand why DNA doesn't replicate wildly and uncontrollably every time a ...

Cancer is transported from one organ to another by invisible bubbles. Understanding these microscopic messengers could change ...